| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.007 |